DD292382B5 - Verfahren zur herstellung eines parenteral applizierbaren lagerbestaendigen immunstimulierenden praeparats - Google Patents

Verfahren zur herstellung eines parenteral applizierbaren lagerbestaendigen immunstimulierenden praeparats Download PDF

Info

Publication number
DD292382B5
DD292382B5 DD90338431A DD33843190A DD292382B5 DD 292382 B5 DD292382 B5 DD 292382B5 DD 90338431 A DD90338431 A DD 90338431A DD 33843190 A DD33843190 A DD 33843190A DD 292382 B5 DD292382 B5 DD 292382B5
Authority
DD
German Democratic Republic
Prior art keywords
solution
preparation
splenopentin
storage
parenterallically
Prior art date
Application number
DD90338431A
Other languages
German (de)
English (en)
Other versions
DD292382A5 (de
Inventor
Ingrid Dr Rer Nat Wolf
Original Assignee
Berlin Chemie Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Berlin Chemie Ag filed Critical Berlin Chemie Ag
Priority to DD90338431A priority Critical patent/DD292382B5/de
Priority to AT91102431T priority patent/ATE88903T1/de
Priority to DE9191102431T priority patent/DE59100098D1/de
Priority to EP91102431A priority patent/EP0445581B1/de
Priority to ES91102431T priority patent/ES2055469T3/es
Priority to CA002037531A priority patent/CA2037531A1/en
Priority to JP3038808A priority patent/JPH0692315B2/ja
Publication of DD292382A5 publication Critical patent/DD292382A5/de
Publication of DD292382B5 publication Critical patent/DD292382B5/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/32—Thymopoietins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Rheumatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pain & Pain Management (AREA)
  • Communicable Diseases (AREA)
  • Endocrinology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Oncology (AREA)
  • Virology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Dermatology (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
DD90338431A 1990-03-06 1990-03-06 Verfahren zur herstellung eines parenteral applizierbaren lagerbestaendigen immunstimulierenden praeparats DD292382B5 (de)

Priority Applications (7)

Application Number Priority Date Filing Date Title
DD90338431A DD292382B5 (de) 1990-03-06 1990-03-06 Verfahren zur herstellung eines parenteral applizierbaren lagerbestaendigen immunstimulierenden praeparats
AT91102431T ATE88903T1 (de) 1990-03-06 1991-02-20 Parenteral applizierbares lagerbestaendiges immunstimulierendes praeparat, verfahren zu seiner herstellung und dessen verwendung.
DE9191102431T DE59100098D1 (de) 1990-03-06 1991-02-20 Parenteral applizierbares lagerbestaendiges immunstimulierendes praeparat, verfahren zu seiner herstellung und dessen verwendung.
EP91102431A EP0445581B1 (de) 1990-03-06 1991-02-20 Parenteral applizierbares lagerbeständiges immunstimulierendes Präparat, Verfahren zu seiner Herstellung und dessen Verwendung
ES91102431T ES2055469T3 (es) 1990-03-06 1991-02-20 Preparado inmunoestimulante, quimicamente estable y de aplicacion parenteral; procedimiento para su produccion y su aplicacion.
CA002037531A CA2037531A1 (en) 1990-03-06 1991-03-04 Preparation, which stimulates the immune system, can be applied parenterally and has a long shelf life, and method forproducing it
JP3038808A JPH0692315B2 (ja) 1990-03-06 1991-03-05 腸管外投与しうる、貯蔵安定な、免疫刺激性製剤及びこれを製造する方法

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DD90338431A DD292382B5 (de) 1990-03-06 1990-03-06 Verfahren zur herstellung eines parenteral applizierbaren lagerbestaendigen immunstimulierenden praeparats

Publications (2)

Publication Number Publication Date
DD292382A5 DD292382A5 (de) 1991-08-01
DD292382B5 true DD292382B5 (de) 1994-03-24

Family

ID=5616877

Family Applications (1)

Application Number Title Priority Date Filing Date
DD90338431A DD292382B5 (de) 1990-03-06 1990-03-06 Verfahren zur herstellung eines parenteral applizierbaren lagerbestaendigen immunstimulierenden praeparats

Country Status (7)

Country Link
EP (1) EP0445581B1 (es)
JP (1) JPH0692315B2 (es)
AT (1) ATE88903T1 (es)
CA (1) CA2037531A1 (es)
DD (1) DD292382B5 (es)
DE (1) DE59100098D1 (es)
ES (1) ES2055469T3 (es)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20100058559A (ko) * 2007-09-11 2010-06-03 몬도바이오테크 래보래토리즈 아게 스플레노펜틴 및 티모펜틴의 배합물 및 약제에서 이의 용도
ITMI20081652A1 (it) * 2008-09-16 2010-03-17 Antica Ritrovati Medicinal I S A R M Srl Soc Composizioni transdermiche per immunoterapia specifica iposensibilizzante
RU2698707C1 (ru) * 2019-04-29 2019-08-29 Федеральное государственное бюджетное научное учреждение "Федеральный Алтайский научный центр агробиотехнологий" (ФГБНУ ФАНЦА) Способ производства биогенных препаратов

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3146598A1 (de) * 1981-11-25 1983-07-07 Hoechst Ag, 6230 Frankfurt "neue peptide und verfahren zu ihrer herstellung"
DD271267A1 (de) * 1988-03-31 1989-08-30 Akad Wissenschaften Ddr Verfahren zur herstellung eines mittels zur normalisierung des immunsystems
HU199878B (en) * 1987-06-19 1990-03-28 Berlin Chemie Veb Process for producing acylated splenopentynes and pharmaceutical compositions comprising such compounds as active ingredient
DD263994A1 (de) * 1987-07-09 1989-01-18 Univ Halle Wittenberg Verfahren zur herstellung von oligodesoxyribonucleotiden zur splenopentinexpression
NZ229004A (en) * 1988-05-19 1993-09-27 Immunobiology Res Inst Inc Tetrapeptides having t cell helper acitivity
DD273980B5 (de) * 1988-07-12 1994-04-14 Berlin Chemie Ag Verfahren zur Herstellung von Insulin-Pr{paraten zur rektalen Anwendung
DD296084A5 (de) * 1989-07-27 1991-11-21 Adw Verfahren zur herstellung von humanen spleninderivaten

Also Published As

Publication number Publication date
JPH0692315B2 (ja) 1994-11-16
ATE88903T1 (de) 1993-05-15
JPH04211611A (ja) 1992-08-03
EP0445581B1 (de) 1993-05-05
EP0445581A1 (de) 1991-09-11
DE59100098D1 (de) 1993-06-09
ES2055469T3 (es) 1994-08-16
DD292382A5 (de) 1991-08-01
CA2037531A1 (en) 1991-09-07

Similar Documents

Publication Publication Date Title
DE69329651T3 (de) Wässrige arzneizusammensetzung, welche das menschliche wachstumshormon enthält
DE3240177C2 (es)
EP0674524B1 (de) Stabile lyophilisierte pharmazeutische zubereitungen von g-csf
DE3536896C2 (de) Lyophilisiertes, ein Anthracyclinglycosid enthaltendes pharmazeutisches Präparat und Verfahren zur Herstellung einer sterilen injizierbaren Lösung hieraus
EP0947200B1 (de) Cetrorelixacetat enthaltende Zusammensetzung zur Behandlung weiblicher Infertilität und zur Gonadenprotektion
DE68904922T2 (de) Piroxicam in waessrigen loesungen enthaltende arzneizubereitungen und verfahren zu deren herstellung.
EP0607156A1 (de) Verfahren zur herstellung von humanproteinhaltigen, konservierten arzneimitteln für infusions- oder injektionszwecke.
EP1565160B1 (de) Darreichungsform für pharmazeutisch aktive peptide mit anhaltender wirkstofffreigabe und verfahren zu deren herstellung
EP0430200A1 (de) Arzneimittel zur subkutanen oder intramuskulären Applikation enthaltend Polypeptide
DE3782828T2 (de) Interleukin-2-zusammensetzungen.
DE69000640T2 (de) Stabilisierte kalcitoninzubereitung.
EP1806361B1 (de) Erythropoietin-Flüssigformulierung
DE69837159T2 (de) Verfahren zur herstellung einer einzeldosisspritze mit lyophilisierter proteinmischung zur verabreichung eines volumens von weniger als 0,5 ml
EP1448221B1 (de) Injektionslösung eines lhrh-antagonisten
DE2608079C2 (de) Arzneipräparate in Form eines Trockenpräparates in Pulverform zur Herstellung von Injektionen durch Zugabe eines wäßrigen Verdünnungsmittels
DD292382B5 (de) Verfahren zur herstellung eines parenteral applizierbaren lagerbestaendigen immunstimulierenden praeparats
DE60020939T2 (de) Salze von pharmakologisch aktiven peptiden mit verzögerter wirkstofffreigabe und deren herstellung
EP0187361A2 (de) Präparate mit verzögerter Wirkung, Verfahren zu deren Herstellung sowie entprechende Mittel zur Human- bzw. veterinärmedizinischen Anwendung
EP0528314A1 (de) Verfahren zur Herstellung von Humanprotein-enthaltenden, gut verträglichen Arzneimitteln für Infusions- oder Injektionszwecke
DE60318310T2 (de) Injizierbare arzneimittel die ein anthracendionderivat, mit antitumoraktivität, enthalten
DE3044753C2 (es)
EP0458949B1 (de) Stabilisierung von k1k2p pro
EP0204737A1 (de) Präparat zur intramuskulären injektion von medikamenten, vitaminen oder impfstoffen.
DE3341435T1 (de) Pharmazeutisches Mittel, enthaltend ein α-Endorfinfragment
DE2238545A1 (de) Corticotropin-peptide enthaltende arzneimittel und verfahren zu ihrer herstellung

Legal Events

Date Code Title Description
B5 Patent specification, 2nd publ. accord. to extension act
IF04 In force in the year 2004

Expiry date: 20100307